Navigation Links
Penn Medicine's Daniel J. Rader, M.D., receives AHA's Clinical Research Prize
Date:11/5/2012

LOS ANGELES - Daniel J. Rader, MD, professor of Medicine and chief, Division of Translational Medicine and Human Genetics at the Perelman School of Medicine at the University of Pennsylvania, has been awarded the American Heart Association's (AHA) Clinical Research Prize for developing new methods to identify factors regulating the metabolism of fat particles in the bloodstream and testing their impact on the development of atherosclerosis. Dr. Rader received the award today during the opening ceremony of the AHA Scientific Sessions in Los Angeles, CA.

Dr. Rader has spent the last two decades working in the field of lipoprotein biology and atherosclerosis, and is a widely recognized international leader in this field. His basic research laboratory focuses on genetic and pharmacologic regulation of lipoprotein metabolism and atherosclerosis, and he directs a translational research program focusing on new pathways involved in lipoprotein metabolism and atherosclerosis discovered through human genetics studies and novel approaches to treatment of dyslipidemia and atherosclerotic cardiovascular disease.

Dr. Rader has a particular interest in the metabolism of HDL (the "good cholesterol") and its relationship to atherosclerosis. In recent research, he has illuminated pathways of HDL-mediated 'reverse cholesterol transport' and has shown that the functional ability of HDL to extract cholesterol from cells is a better predictor of coronary disease than HDL cholesterol blood levels. In addition, Rader and his team have helped to understand how new genes associated with dyslipidemia and coronary artery disease work to influence these conditions. Finally, Rader and his team demonstrated the potential usefulness of a drug that works through a new pathway to lower LDL (the "bad cholesterol") in patients with a severe form of inherited high cholesterol.

He is a Distinguished Fellow of the International Atherosclerosis Society, a member o
'/>"/>

Contact: Jessica Mikulski
jessica.mikulski@uphs.upenn.edu
215-796-4829
University of Pennsylvania School of Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Normalizing tumor blood vessels improves delivery of only the smallest nanomedicines
2. DNA Testing Finds Allergens, Toxins in Traditional Chinese Medicines
3. Not taking gastroprotective drugs prescribed with anti-inflammatory medicines
4. Nearly 1 in 4 grandparents store prescription medicines where children can easily find them
5. Nanomedicines promise fewer side effects in treating cancer
6. New technology represents next-generation tool for detecting substandard and counterfeit medicines
7. New research reveals extent of poor-quality antimalarial medicines in South American countries
8. Toward medicines that recruit the bodys natural disease-fighting proteins
9. Strategy developed to improve delivery of medicines to the brain
10. Popular pain-relieving medicines linked to hearing loss in women
11. Edith Mitchell, M.D., FACP, named 2012 recipient of ASCO Humanitarian Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... TheCelebrityDresses.com, a popular online store selling celebrity ... summer fashion cocktail dresses. The company carries more than ... be suitable for a wide variety of summer events ... and make high quality trendy special occasion dresses ... quality satin, chiffon and cotton. Their products feature a ...
(Date:6/2/2015)... 2015 Consumer Reports, the world’s ... announced its commitment to help wipe out antibiotic-resistant ... of antibiotics sicken about 2.25 million Americans each ... for Disease Control and Prevention. , The initiative ... Marta Tellado participating in the White House Forum ...
(Date:6/2/2015)... 2015 Amercanex, the American Cannabis ... to become Amercanex’s new Chief Technology Officer. Amercanex ... which cultivators, wholesale distributors and retail vendors can ... fully transparent intra-state market. , Jim Miller is ... technology space, helping innovative technology companies deliver on ...
(Date:6/2/2015)... Colleen’s Dream Foundation , with fundraising help from ... to support ovarian cancer research conducted by Cheng Wang, Ph.D. ... Colleen’s Dream Foundation Board of Directors. , Cundiff says the ... Colleen’s Dream Foundation and they couldn’t have picked a better ... a rising star in the ovarian cancer world,” says Cundiff. ...
(Date:6/2/2015)... 2015 Each year, Cosmetic Executive Women ... Awards. This year, the organization’s members – 8,000 industry ... the QVC® Beauty Quest Award at the 2015 Beauty ... (ME) Technology and 2-in-1 approach to skincare differentiated it ... brand’s loyal consumer and professional fan bases, QVC has ...
Breaking Medicine News(10 mins):Health News:Consumer Reports Aims to Stop the Spread of Superbugs 2Health News:Consumer Reports Aims to Stop the Spread of Superbugs 3Health News:Amercanex Names Jim Miller to CTO Position 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 2Health News:Colleen’s Dream Foundation Grants $70,000 to the University of Nebraska Medical Center (UNMC) to Support Ovarian Cancer Research 3Health News:Scalisi Skincare Wins Coveted CEW QVC Beauty Quest Award for Innovative and Patented Formulation 2
... Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ) announces the following webcast:, ... conjunction with the 2009 ... corporate update will be presented by Stanley T. Crooke, M.D., ... Executive Officer of Isis., When: Tuesday, June 2, 2009, ...
... VIDEO ALERT: Additional audio and video resources, including excerpts ... the research, are available on the Mayo Clinic ... Mayo Clinic compared two popular television shows, CSI and ... clear differences between media portrayals of violent deaths versus ...
... Health Care CostsHARRISBURG, Pa., May 19 A budget ... or eliminate vital access to health care and services ... Everette James warned today."In today,s economic climate, access to ... Pennsylvanians. The Department of Health,s programs to expand access ...
... May 19 Boston Scientific Corporation (NYSE: BSX ... rating outlook to positive from stable, while affirming the Company,s ... reflects:, , ... its drug-eluting stent (DES) business and returning its cardiac rhythm ...
... Study Highlights the Clinical Success of Dental Implants ... 19 BioHorizons, a leader in the dental ... three-year prospective, controlled, multi-center study of implants with ... observed for Laser-Lok in vitro and ...
... in the womb , , TUESDAY, May 19 (HealthDay News) ... to become a regular smoker as a teen and ... University of Arizona researchers. , "Somehow smoke is changing ... Grad, an associate professor of clinical pediatrics at the ...
Cached Medicine News:Health News:Webcast Alert: Isis Pharmaceuticals To Provide General Corporate Update in Conjunction with 2009 Annual Meeting of Stockholders 2Health News:CSI: Mayo Clinic Researchers Find Television Shows Inaccurately Portray Violent Crime 2Health News:Senate's Proposed Budget Threatens the Health of Millions of Pennsylvanians 2Health News:Fitch Raises Boston Scientific's Rating Outlook to Positive 2Health News:Fitch Raises Boston Scientific's Rating Outlook to Positive 3Health News:BioHorizons Reports on Comparative 3-Year Dental Implant Study Showing Significant Crestal Bone and Soft Tissue Retention Using Laser-Lok(R) Microchannels 2Health News:BioHorizons Reports on Comparative 3-Year Dental Implant Study Showing Significant Crestal Bone and Soft Tissue Retention Using Laser-Lok(R) Microchannels 3Health News:Kids More Apt to Smoke If Mom Did While Pregnant 2Health News:Kids More Apt to Smoke If Mom Did While Pregnant 3
(Date:6/1/2015)... , June 1, 2015   Regulus ... biopharmaceutical company leading the discovery and development of ... Kleanthis G. Xanthopoulos , Ph.D. has resigned as ... member of Regulus, Board of Directors, effective today, ...  Paul Grint, M.D., who previously served as Chief ...
(Date:6/1/2015)... The nuclear imaging market is estimated to grow to ... Nuclear medicine is the use of radioisotopes for the ... imaging used commonly are PET and SPECT. Till recently, ... applications like nuclear cardiology procedures. However, the trend is ... molybdenum-99 isotope which is in turn will lead to ...
(Date:6/1/2015)... DURHAM, N.C. , June 1, 2015  bioMérieux, ... vitro diagnostics, has been invited to join the ... of antibiotic use in the U.S. as a means ... various sectors, will gather tomorrow, June 2, 2015, to ... next five years to slow the emergence of antibiotic-resistant ...
Breaking Medicine Technology:Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 2Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 3Regulus' Kleanthis G. Xanthopoulos, Ph.D., to Step Down as President and Chief Executive Officer 4North America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019) 2North America Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019) 3bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 2bioMerieux Honored to Participate in the White House Forum on Antibiotic Stewardship 3
... Conference on Avian,Influenza at France's Pasteur Institute, PARIS, ... of,Novavax Inc.'s pandemic influenza vaccine provided protection,against a ... data presented here today at the Second International,Conference ... show that two 0.6 microgram doses of Novavax's,virus-like ...
... of Rare but Devastating,Condition , LONDON, June 1, ... of Leicester and have today (Friday June 1),announced ... rare but,devastating medical condition that can affect children ... clinicians and scientists from the two,universities have already ...
Cached Medicine Technology:Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 2Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 3Novavax Pandemic Flu Vaccine Provided Protection Against a Lethal,Challenge of Live Virus, Pre-Clinical Data Show 4World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 2World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 3World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 4World First Medical Treatment Announced by Researchers at Queen,Mary University London and University of Leicester 5
... C spins up to 25,000 x g for quick ... and ease of use. The Model 5417 C is ... a cold room and can accommodate a variety of ... , Spin up to 16,400 rpm; 25,000 x ...
... laboratory floor model centrifuge meets UL and ... suitable for use in Class 1, Group ... gasoline, petroleum, naphtha, benzol, lacquer, solvent vapors ... is so strict that the EXD design ...
... Hybridization Oven/Shaker rigidly controls the temperature ... of hybridization and washing steps. This ... of nucleic acids and proteins immobilized ... with radioactive and nonradioactive labeling systems ...
... Oven with circular clear acrylic chamber for ... HybriCycler Oven features microprocessor operation for precise ... the unit., Carousel rotates at 11 ... ,easily removable , Bottle Capacity - ...
Medicine Products: